San Ramon, CA, United States of America

Ganapathy N Sarma

This inventor holds 1 USPTO granted patent and 10 published patent applications. Top assignee: Heidelberg Pharma Research Gmbh. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ganapathy N Sarma. Retrieved from https://idiyas.com/inventor/ganapathy-n-sarma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ganapathy N Sarma: Innovator in Antibody-Drug Conjugates

Introduction

Ganapathy N Sarma is a notable inventor based in San Ramon, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates.

Latest Patents

Ganapathy holds a patent for "Amatoxin Antibody-Drug Conjugates and Uses Thereof." This innovative work showcases his expertise in creating targeted therapies that can improve treatment outcomes for patients.

Career Highlights

He is currently associated with Heidelberg Pharma Research GmbH, where he continues to advance research in the field of drug development. His work is pivotal in the ongoing efforts to enhance the efficacy of cancer treatments.

Collaborations

Ganapathy has collaborated with esteemed colleagues such as Charlotte Fenton McDonagh and Torsten Hechler, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ganapathy N Sarma's contributions to the field of biotechnology, particularly through his patent on antibody-drug conjugates, highlight his role as a key innovator in the industry. His ongoing work at Heidelberg Pharma Research GmbH continues to pave the way for advancements in targeted therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…